文献速递临床试验与 GCP

电针治疗肺癌患者失眠的疗效与安全性:随机对照试验研究方案

Efficacy and safety of electro-acupuncture (EA) on insomnia in patients with lung cancer: study protocol of a randomized controlled trial.
PubMed 文献 · Trials · 2020-09-14

本研究为多中心随机单盲假针对照试验方案,计划将252例肺癌相关失眠患者按1:1随机分为电针组和假电针组,每周治疗3次共8周并随访12周。主要结局为匹兹堡睡眠质量指数(PSQI),次要结局包括体动记录仪睡眠参数、QLQ-C30和PHQ-9评分,不良事件用TESS评估。该大样本试验旨在评估电针疗效,若有效可填补肺癌相关失眠治疗空白。

要点

  • 电针每周3次共8周,随访12周,主要结局为PSQI。
  • 252例肺癌相关失眠患者按1:1随机分为电针组与假电针组。
  • 次要结局包括体动记录仪参数、QLQ-C30和PHQ-9,不良事件用TESS评估。

核心结论

  • 该大样本试验方案将评估电针治疗肺癌患者失眠的疗效与安全性。
  • 若被证实有效,可为肺癌相关失眠提供有前景的干预选择并填补治疗空白。

研究设计与样本

  • 多中心随机单盲假针对照试验方案,计划纳入252例肺癌相关失眠患者。
  • 按1:1随机分为电针组和假电针组,每周治疗3次共8周,随访12周。
  • 分析基于意向性治疗(ITT)原则,使用SPSS 24.0进行t检验、秩和检验、卡方检验等,双侧显著性水平设为5%。

主要发现

  • 原文为研究方案,未报告疗效或安全性结果。

关键数值与推荐

  • 主要结局为匹兹堡睡眠质量指数(PSQI)。
  • 次要结局包括体动记录仪睡眠参数、QLQ-C30评分和PHQ-9评分。
  • 所有不良事件采用治疗 emergent 症状量表(TESS)评估。

临床怎么用

  • 原文为试验方案,尚未提供临床实践推荐。

局限性

  • 原文为研究方案,尚未报告实际试验结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cancer-related insomnia (CRI) is one of the most prevalent complaints among cancer survivors and severely impairs patients' quality of life. As a popular non-pharmacological alternative treatment, acupuncture provides a good clinical curative effect on insomnia. The aim of this trial is to evaluate efficacy and safety of electro-acupuncture on insomnia in patients with lung cancer. METHOD: This is a protocol for a multicenter randomized single-blinded sham-controlled trial. We will randomly assign 252 eligible patients with lung cancer-related insomnia into two groups at a ratio of 1:1, the treatment group (EA) and the control group (sham EA). All treatment will be given 3 times per week for 8 weeks, and a 12-week follow-up will be conducted. The primary outcome will be measured by the Pittsburgh Sleep Quality Index (PSQI). The secondary outcomes will include sleep parameters recorded from the actigraphy, scores from Quality of Life Questionnaire Core-30 (QLQ-C30), and Patient Health Questionnaire-9 (PHQ-9). All adverse effects during the trial will be assessed by the Treatment Emergent Symptom Scale (TESS). All analyses will be based on ITT principle and performed with the statistical software SPSS (version 24.0) by t test, rank-sum test, chi-square, and so on. A two-sided significance level will be set at 5%. DISCUSSION: This large-sample trial protocol will evaluate the efficacy of electro-acupuncture on insomnia in patients with lung cancer. This protocol, if proven to be effective, will contribute to filling the gap in treatment options in the CRI field and provide a promising intervention for insomnia in lung cancer survivors. TRIAL REGISTRATION: ChiCTR ChiCTR1900026395. Registered on 8 October 2019, http://www.chictr.org.cn/showproj.aspx?proj=44068.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Yue H, Zhou S, Wu H, et al. Efficacy and safety of electro-acupuncture (EA) on insomnia in patients with lung cancer: study protocol of a randomized controlled trial. Trials. 2020. PMID: 32928276. doi:10.1186/s13063-020-04721-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。